Co-Diagnostics, Inc.
CODX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,915 | $6,812 | $34,218 | $97,886 |
| % Growth | -42.5% | -80.1% | -65% | – |
| Cost of Goods Sold | $999 | $4,185 | $5,481 | $11,575 |
| Gross Profit | $2,916 | $2,627 | $28,737 | $86,311 |
| % Margin | 74.5% | 38.6% | 84% | 88.2% |
| R&D Expenses | $20,980 | $22,963 | $17,438 | $14,962 |
| G&A Expenses | $16,157 | $14,279 | $14,263 | $11,551 |
| SG&A Expenses | $20,640 | $21,140 | $21,608 | $24,948 |
| Sales & Mktg Exp. | $4,483 | $6,861 | $7,345 | $13,398 |
| Other Operating Expenses | $1,377 | $1,230 | $16,671 | $335 |
| Operating Expenses | $42,997 | $45,333 | $55,717 | $40,246 |
| Operating Income | -$40,081 | -$42,706 | -$26,980 | $46,065 |
| % Margin | -1,023.7% | -626.9% | -78.8% | 47.1% |
| Other Income/Exp. Net | $2,500 | $4,596 | $8,133 | -$429 |
| Pre-Tax Income | -$37,582 | -$38,111 | -$18,847 | $45,636 |
| Tax Expense | $57 | -$2,778 | -$4,609 | $8,977 |
| Net Income | -$37,639 | -$35,333 | -$14,238 | $36,659 |
| % Margin | -961.4% | -518.7% | -41.6% | 37.5% |
| EPS | -1.24 | -1.2 | -0.45 | 1.27 |
| % Growth | -3.3% | -166.7% | -135.4% | – |
| EPS Diluted | -1.24 | -1.2 | -0.45 | 1.23 |
| Weighted Avg Shares Out | 30,335 | 29,347 | 31,479 | 28,875 |
| Weighted Avg Shares Out Dil | 30,335 | 29,347 | 31,479 | 29,904 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,092 | $1,162 | $704 | $46 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,377 | $1,230 | $1,283 | $335 |
| EBITDA | -$38,704 | -$41,476 | -$10,309 | $46,400 |
| % Margin | -988.6% | -608.9% | -30.1% | 47.4% |